Literature DB >> 12954181

Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study.

Michael A A O'Neill1, George J Vine, Anthony E Beezer, Alistair H Bishop, Jonathan Hadgraft, Chloé Labetoulle, Michael Walker, Phillip G Bowler.   

Abstract

The studies reported here have been undertaken to assess the potential use of isothermal microcalorimetry in studying the antimicrobial efficacy of wound dressings that contain antimicrobial agents. The microcalorimetric technique allows non-invasive and non-destructive analysis to be performed directly on a test sample, regardless of whether it is homogeneous or heterogeneous in nature. Microcalorimetry is an established procedure that offers quantitative measurements and has the distinct advantage over traditional antimicrobial test methodologies in that calorimetric measurements are made continuously over real-time, thus the dynamic response of microorganisms to an antimicrobial agent is observed in situ. The results described in this paper are for interaction of two silver-containing wound care products AQUACEL Ag Hydrofiber (ConvaTec, Deeside, UK) and Acticoat 7 with SILCRYST (Smith and Nephew Healthcare, UK) with the wound pathogenic organisms Staphylococcus aureus and Pseudomonas aeruginosa. Both dressings are shown, microcalorimetrically, to have the capacity to kill these common wound pathogens within 1-2 h of contact. A dose-response study was conducted with the AQUACEL Ag dressing. Microcalorimetry is shown to be rapid, simple and effective in the study of the antimicrobial properties of gel forming wound dressings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954181     DOI: 10.1016/s0378-5173(03)00361-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

Review 1.  Silver dressings: their role in wound management.

Authors:  David J Leaper
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

2.  A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.

Authors:  Pornprom Muangman; Chanin Pundee; Supaporn Opasanon; Saipin Muangman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

Review 3.  Approach to infected skin ulcers.

Authors:  Christopher Frank; Imaan Bayoumi; Claire Westendorp
Journal:  Can Fam Physician       Date:  2005-10       Impact factor: 3.275

4.  The effect of a silver-containing Hydrofiber dressing on superficial wound bed and bacterial balance of chronic wounds.

Authors:  Pat Coutts; R Gary Sibbald
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

5.  Characterization of the mechanism of the Staphylococcus aureus cell envelope by bacitracin and bacitracin-metal ions.

Authors:  Zu-De Qi; Yi Lin; Bo Zhou; Xiao-Di Ren; Dai-Wen Pang; Yi Liu
Journal:  J Membr Biol       Date:  2008-10-15       Impact factor: 1.843

6.  Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Authors:  John S Graham; Robert P Chilcott; Paul Rice; Stephen M Milner; Charles G Hurst; Beverly I Maliner
Journal:  J Burns Wounds       Date:  2005-01-05

7.  Rotation Disk Process to Assess the Influence of Metals and Voltage on the Growth of Biofilm.

Authors:  Dana M Barry; Paul B McGrath
Journal:  Materials (Basel)       Date:  2016-07-12       Impact factor: 3.623

8.  Electroceutical Treatment of Pseudomonas aeruginosa Biofilms.

Authors:  Devendra H Dusane; Varun Lochab; Travis Jones; Casey W Peters; Devin Sindeldecker; Amitava Das; Sashwati Roy; Chandan K Sen; Vish V Subramaniam; Daniel J Wozniak; Shaurya Prakash; Paul Stoodley
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

9.  Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C.

Authors:  Erin M McCarrell; Simon W J Gould; Mark D Fielder; Alison F Kelly; Waffa El Sankary; Declan P Naughton
Journal:  BMC Complement Altern Med       Date:  2008-12-15       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.